PIL- Exemestane 25mg Film-coated Tablets: Change history
View Patient Information Leaflet (PIL- Exemestane 25mg Film-coated Tablets)
Last updated on this site: 20 May 2025
The following changes have been notified:
Type IAin, B.II.b.1.a - Addition of Accord Healthcare single member S.A. as secondary packaging site.
Type IAin, B.II.b.2.c.2 - Addition of Accord Healthcare single member S.A. as manufacturer responsible for importation and batch release - Including batch control/testing.
The application is accepted on 19 May 2025.
Last updated on this site: 20 May 2025
The following changes have been notified:
Type IAin, B.II.b.1.a - Addition of Accord Healthcare single member S.A. as secondary packaging site.
Type IAin, B.II.b.2.c.2 - Addition of Accord Healthcare single member S.A. as manufacturer responsible for importation and batch release - Including batch control/testing.
The application is accepted on 19 May 2025.
-
Changes: (Updated: 20 May 2025)
The following changes have been notified:
Type IAin, B.II.b.1.a - Addition of Accord Healthcare single member S.A. as secondary packaging site.
Type IAin, B.II.b.2.c.2 - Addition of Accord Healthcare single member S.A. as manufacturer responsible for importation and batch release - Including batch control/testing.
The application is accepted on 19 May 2025.
-
Changes: (Updated: 25 Apr 2023)
Description of update: The proposed change is: C.I.2.a: Update of SmPC and PIL in-line with reference product information: Aro-masin 25 mg coated tablets; Procedure number: NL/H/4752/001/DC; MAH: Pfizer Healthcare Ireland, Dublin.
PIL sections updated: 2, 3, 4, 6.
-
Changes: (Updated: 02 Dec 2022)
Change to section 1 - what the product is
Change to section 2 - what you need to know - warnings and precautions
Change to section 2 - interactions with other medicines, food or drink
Change to section 2 - driving and using machines
Change to section 4 - possible side effects
Change to section 6 - date of revision
-
Changes: (Updated: 20 Sep 2022)
initial upload